Suppr超能文献

致癌性KRAS与胰腺癌发生中的表皮生长因子受体环——与许可节点的联系

Oncogenic KRAS and the EGFR loop in pancreatic carcinogenesis-A connection to licensing nodes.

作者信息

Schneeweis Christian, Wirth Matthias, Saur Dieter, Reichert Maximilian, Schneider Günter

机构信息

a II. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München , München , Germany.

b German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) , Heidelberg , Germany.

出版信息

Small GTPases. 2018 Nov 2;9(6):457-464. doi: 10.1080/21541248.2016.1262935. Epub 2017 Jan 20.

Abstract

EGFR signaling has a critical role in oncogenic KRAS-driven tumorigenesis of the pancreas, whereas it is dispensable in other organs. The complex signaling network engaged by oncogenic KRAS and its modulation by EGFR signaling, remains incompletely understood. In order to study early signaling events activated by oncogenic KRAS in the pancreas, we recently developed a novel model system based on murine primary pancreatic epithelial cells enabling the time-specific expression of mutant Kras from its endogenous promoter. Here, we discuss our findings of a Kras-induced autocrine EGFR loop, how this loop is integrated by the MYC oncogene, and point to possible translational implications.

摘要

表皮生长因子受体(EGFR)信号传导在致癌性KRAS驱动的胰腺肿瘤发生中起关键作用,而在其他器官中则并非必需。致癌性KRAS参与的复杂信号网络及其受EGFR信号传导的调节,目前仍未完全明确。为了研究致癌性KRAS在胰腺中激活的早期信号事件,我们最近基于小鼠原代胰腺上皮细胞开发了一种新型模型系统,能够从其内源启动子实现突变型Kras的时间特异性表达。在此,我们讨论关于Kras诱导的自分泌EGFR环的研究结果,该环如何被MYC癌基因整合,并指出可能的转化意义。

相似文献

1
Oncogenic KRAS and the EGFR loop in pancreatic carcinogenesis-A connection to licensing nodes.
Small GTPases. 2018 Nov 2;9(6):457-464. doi: 10.1080/21541248.2016.1262935. Epub 2017 Jan 20.
2
Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells.
Oncogene. 2016 Jul 21;35(29):3880-6. doi: 10.1038/onc.2015.437. Epub 2015 Nov 23.
3
NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
Gastroenterology. 2015 May;148(5):1024-1034.e9. doi: 10.1053/j.gastro.2015.01.033. Epub 2015 Jan 23.
4
Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Gastroenterology. 2014 Nov;147(5):1119-33.e4. doi: 10.1053/j.gastro.2014.08.002. Epub 2014 Aug 12.
5
CXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer.
Oncotarget. 2016 Feb 9;7(6):7280-96. doi: 10.18632/oncotarget.6906.
9
Targeting integrin-linked kinase to suppress oncogenic KRAS signaling in pancreatic cancer.
Small GTPases. 2018 Nov 2;9(6):452-456. doi: 10.1080/21541248.2016.1251383. Epub 2016 Dec 9.

引用本文的文献

2
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer.
Front Oncol. 2024 Jul 17;14:1427802. doi: 10.3389/fonc.2024.1427802. eCollection 2024.
3
MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas.
Carcinogenesis. 2022 Feb 11;43(1):67-76. doi: 10.1093/carcin/bgab097.
5
Rationale for MYC imaging and targeting in pancreatic cancer.
EJNMMI Res. 2021 Oct 12;11(1):104. doi: 10.1186/s13550-021-00843-1.
6
Pumping the brakes on RAS - negative regulators and death effectors of RAS.
J Cell Sci. 2020 Feb 10;133(3):jcs238865. doi: 10.1242/jcs.238865.
8
MTOR inhibitor-based combination therapies for pancreatic cancer.
Br J Cancer. 2018 Feb 6;118(3):366-377. doi: 10.1038/bjc.2017.421. Epub 2018 Jan 2.
9
Tissue-specific tumorigenesis: context matters.
Nat Rev Cancer. 2017 Apr;17(4):239-253. doi: 10.1038/nrc.2017.5. Epub 2017 Mar 3.

本文引用的文献

1
Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design.
Nat Rev Drug Discov. 2016 Nov;15(11):771-785. doi: 10.1038/nrd.2016.139. Epub 2016 Jul 29.
3
Concepts to Target MYC in Pancreatic Cancer.
Mol Cancer Ther. 2016 Aug;15(8):1792-8. doi: 10.1158/1535-7163.MCT-16-0050. Epub 2016 Jul 12.
4
The complexities and versatility of the RAS-to-ERK signalling system in normal and cancer cells.
Semin Cell Dev Biol. 2016 Oct;58:96-107. doi: 10.1016/j.semcdb.2016.06.011. Epub 2016 Jun 24.
5
O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling.
J Mol Biol. 2016 Aug 14;428(16):3282-3294. doi: 10.1016/j.jmb.2016.05.028. Epub 2016 Jun 23.
6
YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling.
Gastroenterology. 2016 Sep;151(3):526-39. doi: 10.1053/j.gastro.2016.05.006. Epub 2016 May 20.
7
KRas, ROS and the initiation of pancreatic cancer.
Small GTPases. 2017 Jan 2;8(1):38-42. doi: 10.1080/21541248.2016.1192714. Epub 2016 May 24.
8
Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy.
Nat Immunol. 2016 Jun;17(6):712-20. doi: 10.1038/ni.3439. Epub 2016 Apr 25.
9
RAS isoforms and mutations in cancer at a glance.
J Cell Sci. 2016 Apr 1;129(7):1287-92. doi: 10.1242/jcs.182873. Epub 2016 Mar 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验